Supramolecular Chemistry
N-Myrtenyl-[2-(2-ethylphenyl)]pyridinium bromide (7b)
9
2-(2-Isopropylphenyl)pyridine (6c)
Prepared similarly to tolylpyridine 6a, with 2-isopropyl-
phenylboronic acid (0.58 g, 3.5 mmol) instead of tolyl-
boronic acid. The product was purified by chromatography
(silica gel; eluent: hexane–ethyl acetate, 9:1) to afford
light brown oil (0.39 g, 78%). 1H NMR: d 8.68 (d,
J ¼ 4.8 Hz, ArZH, 1H), 7.82 (t, J ¼ 7.7 Hz, ArZH, 1H),
7.51–7.34 (m, ArZH, 3H), 7.33–7.28 (m, ArZH, 3H)
ppm. 13C NMR: 161.3, 150.0, 147.6, 141.2, 137.3, 130.7,
129.6, 126.7, 126.5, 125.3, 122.9 (ArC), 30.1 (ArC H),
24.4 (CH3) ppm.
Obtained similarly to pyridinium 7a, using phenylpyridine
6b (0.10 g, 0.55 mmol) instead of phenylpyridine 6a.
1
White solid (89 mg, 41%); m.p. 141–1428C. H NMR
(D2O): d 8.92 (d, J ¼ 6.0 Hz, ArZH, 1H), 8.61 (t,
J ¼ 8.1 Hz, ArZH, 1H), 8.12 (d, J ¼ 6.9 Hz, ArZH, 1H),
8.07 (t, J ¼ 7.2 Hz, ArZH, 1H), 7.66 (t, J ¼ 7.2 Hz,
ArZH, 1H), 7.58 (d, J ¼ 7.0 Hz, ArZH, 1H), 7.49–7.39
(m, ArZH, 2H), 5.26 (d, J ¼ 17.7 Hz, C ¼ CH, 1H),
5.03–4.86 (m, N–CH2, 2H), 2.57–2.45 (m, CH, 1H),
2.40–2.31 (m, ArZCH2, 2H), 2.31–2.20 (m, CH, 2H),
2.08 (br, CH, 1H), 1.89 (q, J ¼ 6.3 Hz, CH, 1H), 1.19 (d,
J ¼ 6.0 Hz, CH3, 3H), 1.15–0.98 (m, CH3,CH, 4H), 0.64
(d, J ¼ 13.8 Hz, CH3, 3H) ppm. 13C NMR (D2O): 155.3
(d, J ¼ 6.8 Hz, ArC), 146.0 (d, J ¼ 3.2 Hz, ArC), 145.6 (d,
J ¼ 3.2 Hz, ArC), 142.3 (d, J ¼ 19.5 Hz, ArC), 140.9 (d,
J ¼ 3.8 Hz, ArC), 131.7 (ArC), 130.9 (d, J ¼ 6.0 Hz,
ArC), 130.3 (ArC), 129.4 (m, ArC), 129.1, 127.3 (ArC),
126.5 (d, J ¼ 8.6 Hz, ArC), 124.3 (d, J ¼ 4.5 Hz, ArC),
61.9 (d, J ¼ 3.4 Hz, NCH2), 43.5 (d, J ¼ 9.8 Hz, myrtenyl-
C), 40.0 (myrtenyl-C), 37.7 (d, J ¼ 7.5 Hz, myrtenyl-
C),31.0, 30.9 (myrtenyl-C), 25.8 (d, J ¼ 10.5 Hz, myrte-
nyl-C), 25.4 (d, J ¼ 2.3 Hz, myrtenyl-C), 20.4 (d,
J ¼ 17.3 Hz, myrtenyl-C), 14.4 (d, J ¼ 4.5 Hz, myrtenyl-
C) ppm. HRMS (ESI) m/z calcd for C23H28N ([M]þ)
318.221626, found 318.221780.
2-(2-tert-Butylphenyl)pyridine (6d)
Prepared similarly to tolylpyridine 6a, with 2-tert-
butylphenylboronic acid (5b; 0.70 g, 4.0 mmol) instead
of tolylboronic acid. The product was purified by
chromatography (silica gel; eluent: hexane–ethyl acetate,
1
17:3) to afford colourless oil (0.15 g, 22%). H NMR: d
8.59 (d, J ¼ 4.6 Hz, ArZH, 1H), 7.79 (t, J ¼ 7.8 Hz,
ArZH, 1H), 7.62 (d, J ¼ 8.0 Hz, ArZH, 1H), 7.42–7.32
(m, ArZH, 3H), 7.25 (t, J ¼ 7.4 Hz, ArZH, 1H), 7.06 (d,
J ¼ 7.5 Hz, ArZH, 1H), 1.19 (s, C(CH3)3, 9H) ppm. 13C
NMR: 164.5, 149.0, 148.8, 142.3, 136.9, 132.5, 128.9,
127.9, 126.2, 126.0, 122.9 (ArZC), 37.2 (C(CH3)2), 32.7
(C(C H3)2) ppm.
N-Myrtenyl-(2-o-tolyl)pyridinium bromide (7a)
N-Myrtenyl-[2-(2-isopropylphenyl)]pyridinium
bromide (7c)
A mixture of o-tolylpyridine (6a; 50 mg, 0.30 mmol) and
(2)-myrtenyl bromide (64 mg, 0.3 mmol) in acetone
(15 mL) was refluxed for 12 h. Addition of diethyl ether
(10 mL) resulted in the formation of the title compound as
A mixture of phenylpyridine 6c (0.10 g, 0.51 mmol) and
(2)-myrtenyl bromide (0.11 g, 0.51 mmol) in acetonitrile
was heated to 508C for 12 h. The product was crystallised
from acetonitrile/diethyl ether (2:1) to afford a white solid
that immediately turned to a thick oil when exposed to air
1
a white solid (31 mg, 27%); m.p. 167–1688C. H NMR
(D2O): d 8.93 (d, J ¼ 6.3 Hz, ArZH, 1H), 8.62 (t,
J ¼ 7.2 Hz, ArZH, 1H), 8.11 (t, J ¼ 6.3 Hz, ArZH, 1H),
8.03 (d, J ¼ 7.8 Hz, ArZH, 1H), 7.60 (t, J ¼ 6.3 Hz,
ArZH, 1H), 7.52–7.41 (m, ArZH, 3H), 5.23 (d,
J ¼ 14.7 Hz, C ¼ CH, 1H), 4.98 (m, N–CH2, 2H), 2.34
(m, CH2, 1H), 2.27 (br, CH2, 2H), 2.16 (s, ArZCH3, 3H),
2.08 (br, CH, 1H), 1.88 (m, CH2, 1H), 1.19 (d, J ¼ 4.8 Hz,
CH3, 3H), 1.01 (t, J ¼ 11.4 Hz, CH2, 1H), 0.62 (d,
J ¼ 7.5 Hz, CH3, 3H) ppm. 13C NMR (D2O): 156.2 (d,
J ¼ 6.0 Hz, ArC), 146.5 (d, J ¼ 4.5 Hz, ArC), 145.9 (s,
ArC), 141.6 (s, ArC), 137.0 (d, J ¼ 21 Hz, ArC), 132.0
(ArC), 131.5 (d, J ¼ 12.8 Hz, ArC), 131.4 (s, ArC), 131.3
(d, J ¼ 8.3 Hz, ArC), 129.9 (s, ArC), 129.5 (ArC), 127.6
(ArC), 126.5 (d, J ¼ 7.5 Hz, ArC), 124.8 (d, J ¼ 7.5 Hz,
ArC), 62.4 (d, J ¼ 3.2 Hz, NCH2), 44.0 (d, J ¼ 10.5 Hz,
myrtenyl-C), 40.5 (d, J ¼ 2.6 Hz, myrtenyl-C), 38.1 (d,
J ¼ 8.3 Hz, myrtenyl-C), 31.5 (myrtenyl-C), 31.3
(d, J ¼ 6.3 Hz, myrtenyl-C), 25.7 (myrtenyl-C), 20.6 (d,
J ¼ 19.5 Hz, myrtenyl-C), 19.3 (d, J ¼ 11.3 Hz, myrtenyl-
C) ppm. HRMS (ESI) m/z calcd for C22H26N ([M]þ)
304.205976, found 304.206121.
1
(50 mg, 24%). H NMR (D2O): d 8.87 (d, J ¼ 6.0 Hz,
ArZH, 1H), 8.56 (t, J ¼ 7.5 Hz, ArZH, 1H), 8.09–8.00
(m, ArZH, 2H), 7.68–7.64 (m, ArZH, 2H), 7.44–7.38
(m, ArZH, 2H), 7.34–7.32 (m, ArZH, 1H), 5.34 (d,
J ¼ 19.2 Hz, C ¼ CH, 1H), 4.98–4.71 (m, NCH2, 2H),
2.48–2.38 (m, ArZCH, 1H), 2.38–2.19 (m, CH2, CH,
3H), 2.06 (br, CH, 1H), 1.87 (t, J ¼ 5.4 Hz, CH, 1H), 1.23
(d, J ¼ 6.9 Hz, CH3, 3H), 1.17 (d, J ¼ 4.8 Hz, CH3, 3H),
1.08 (d, J ¼ 6.6 Hz, CH3, 3H), 0.97 (m, CH2, 1H), 0.65 (d,
J ¼ 22.8 Hz, CH3, 3H) ppm. 13C NMR (D2O): 156.2
(d, J ¼ 5.6 Hz, ArC), 147.8, 147.5 (ArC), 146.2 (d,
J ¼ 2.6 Hz, ArC), 145.6 (d, J ¼ 5.0 Hz, ArC), 141.4,
141.1, 132.5 (ArC), 131.4 (d, J ¼ 7.2 Hz, ArC), 130.11–
129.3 (ArC £ 2), 127.5–126.8 (ArC), 126.1–125.7 (m,
ArC), 62.8 (NC H2), 43.9, 40.8 (myrtenyl-C), 38.1 (d,
J ¼ 4.5 Hz, myrtenyl-C), 31.6–31.2 (myrtenyl-C £ 2),
25.6 (myrtenyl-C), 24.6 (d, J ¼ 7.2 Hz, myrtenyl-C),
23.7 (myrtenyl-C), 22.6 (d, J ¼ 8.9 Hz, myrtenyl-C), 20.7
(d, J ¼ 11.4 Hz, myrtenyl-C) ppm. HRMS (ESI) m/z calcd
for C24H30N ([M]þ) 332.237276, found 332.237442.